Senators seek to end patent settlements

07/24/2013 | Bloomberg Businessweek

Sens. Charles Grassley, R-Iowa, and Amy Klobuchar, D-Minn., said at a Senate hearing Tuesday that they hope to eliminate patent settlements between brand-name drugmakers and manufacturers of generic drugs. Grassley and Klobuchar's measure would make patent settlements unlawful unless drugmakers can show they are not anti-competitive. Klobuchar said "it's simply outrageous that consumers are forced to pay higher prices for critical drugs because of brand companies colluding with generic competitors."

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ